With its broad base of expertise, the mission of the Georgia Center for Diabetes Translation Research (GCDTR) is to facilitate and grow Type 2 translation research in diabetes within the state of Georgia. Type 2 translation is defined as research focused on translating approaches that have clearly demonstrated efficacy into real world health care settings, and communities, at risk with an emphasis on reach, sustainability, and widespread implementation.
Emory University, in partnership with Georgia Tech and Morehouse School of Medicine, has received funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to establish the Georgia Center for Diabetes Translation Research (GCDTR). Dr. K. M. Venkat Narayan, Director of the Emory Global Diabetes Research Center at Emory University, along with Co-Directors Mohammad K. Ali and Guillermo Umpierrez, will lead the center.
Dr. Karla Galaviz Wins Diversity Supplement Award
Karla Galaviz won an NIDDK administrative supplement to our GCDTR P30. This award will support her transition into a faculty position at Emory University and a research study focused on addressing diabetes in the HIV Setting. Specifically, Karla will develop a parsimonious, high-performing diabetes risk screening tool for HIV-infected populations. She will then assess the acceptability, clinical applicability, and impact of the tool in routine HIV care. This award represents a promising step towards addressing cardio-metabolic diseases in HIV care and a strong platform to support Karla’s career as an independent investigator.
This Field Epidemiology Training Program Investigators Guide was produced by CDC in collaboration with EGDRC, and was led by Dr. Unjali Gujral at Emory.
Solveig A. Cunninghama, Sara R. Adams, Julie A. Schmittdiel, Mohammed K. Ali
In a cohort study, we examined whether incidence of diabetes was different for individuals with recently diagnosed partners compared to individuals similar on other characteristics but whose partners were never diagnosed with diabetes.
This research studied the largest clinical lifestyle change program in the United States, the Veteran’s Health Administration’s MOVE! program.
Elizabeth K. Ely, Stephanie M. Gruss, Elizabeth T. Luman, Edward W. Gregg, Mohammed K. Ali, Kunthea Nhim, Deborah B. Rolka, and Ann L. Albright
This paper assesses participant-level results from the first 4 years of implementation of the National Diabetes Prevention Program (National DPP), a national effort to prevent type 2 diabetes in those at risk through structured lifestyle change programs.
Endo Grand Round
View All Events >>